BioPharm International
November 02, 2020
Cover Story
33
11
More collaboration and a knowledge-based approach, driven by better analytics and high-throughput system integration, are reducing the risk of failure.
November 02, 2020
Peer-Reviewed Research
33
11
Continuous SEC was shown to increase productivity with the same product quality and yield.
November 02, 2020
Upstream Processing
33
11
PAT advances are enabling improved process understanding, process control, and error prevention.
November 02, 2020
Downstream Processing
33
11
The latest advances in downstream technologies include sterile disconnects for single-use manufacturing systems, ligand technologies for purifying RNA and for COVID-19 vaccines, and an automated perfusion system.
November 01, 2020
Manufacturing
33
11
The shift to single-use technologies is driving the need for innovation in PAT-friendly sensor technologies.
November 01, 2020
Quality/Regulations
33
11
Complex manufacturing processes pose challenges for final product inspection needed to ensure product integrity at commercial launch.
November 01, 2020
Analytics
33
11
Early detection and more sensitive methods of detecting adventitious agents are becoming increasingly critical in bioprocessing.
November 01, 2020
Operations
33
11
Collecting and analyzing data are crucial for creating efficient, automated bioprocesses.
November 01, 2020
Outsourcing
33
11
Single-use equipment, analytics, and automation may add complexity, but they are reducing scale-up costs and timelines.
November 01, 2020
Regulatory Beat
33
11
Experts fear confusion over allocation processes, cold-chain requirements, and IT systems needed to bring a COVID-19 vaccine to market.
November 01, 2020
From the Editor
33
11
Resolving drug shortages starts with identifying the source of the problem.
November 01, 2020
Ask The Expert
33
11
Siegfried Schmitt, vice president, Technical at Parexel, offers insight into FDA’s guidance on performing operations during COVID-19.